Abstract
Malignant pleural effusion represents advanced disease. Management is determined by the patient’s performance status, symptoms and degree of lung re expansion after pleural fluid drainage. The goal of management is control of patient symptoms, with minimum morbidity and maximum patient independence. Pleural fluid evacuation and long term palliation can be achieved by either chemical pleurodesis or patient controlled drainage with a tunneled pleural catheter. Thoughtful patient evaluation is critical to choosing the appropriate palliative option for each individual with malignant pleural effusion.
Keywords: Malignant effusions, pleurodesis, thoracoscopy, tunneled pleural catheter, Decortications, neoplasm, PLEURAL LINING, mesothelial layer, endothelial, fibroblasts, pleural fluid.
Current Respiratory Medicine Reviews
Title:Malignant Pleural Effusion Evaluation and Management
Volume: 8 Issue: 4
Author(s): Jed A. Gorden and Joelle Thirsk Fathi
Affiliation:
Keywords: Malignant effusions, pleurodesis, thoracoscopy, tunneled pleural catheter, Decortications, neoplasm, PLEURAL LINING, mesothelial layer, endothelial, fibroblasts, pleural fluid.
Abstract: Malignant pleural effusion represents advanced disease. Management is determined by the patient’s performance status, symptoms and degree of lung re expansion after pleural fluid drainage. The goal of management is control of patient symptoms, with minimum morbidity and maximum patient independence. Pleural fluid evacuation and long term palliation can be achieved by either chemical pleurodesis or patient controlled drainage with a tunneled pleural catheter. Thoughtful patient evaluation is critical to choosing the appropriate palliative option for each individual with malignant pleural effusion.
Export Options
About this article
Cite this article as:
A. Gorden Jed and Thirsk Fathi Joelle, Malignant Pleural Effusion Evaluation and Management, Current Respiratory Medicine Reviews 2012; 8 (4) . https://dx.doi.org/10.2174/157339812802652170
DOI https://dx.doi.org/10.2174/157339812802652170 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Current Cancer Drug Targets siRNA Modifications and Sub-Cellular Localization: A Question of Intracellular Transport?
Current Pharmaceutical Design Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug Targets
Current Drug Targets Ansamycin Inhibitors of Hsp90: Natures Prototype for Anti-Chaperone Therapy
Current Topics in Medicinal Chemistry Radioiodinated Agents for Imaging Multidrug Resistant Tumors
Medicinal Chemistry The Clinical Impact of Quantitative Cell-free DNA, KRAS, and BRAF Mutations on Response to Anti-EGFR Treatment in Patients with Metastatic Colorectal Cancer
Current Pharmaceutical Design Toward the Development of Inhibitors Directed against Mammalian DDAH Proteins: Considerations from Homology Modeling of DDAH-2 and DDAH Activity Tracing in Tissue Homogenate
Letters in Drug Design & Discovery Bamboo a Supplement to Human Health: A Comprehensive Review on its Ethnopharmacology, Phytochemistry, and Pharmacological Activity
The Natural Products Journal Evaluation of Fluorescence Resonance Energy Transfer Approaches as a Tool to Quantify the Stability of Antisense Oligodeoxynucleotides
Current Pharmaceutical Analysis The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy
Current Drug Targets Hereditary Papillary Renal Carcinoma Type I
Current Molecular Medicine Making the Most of Pathological Specimens: Molecular Diagnosis in Formalin-Fixed, Paraffin Embedded Tissue
Current Drug Targets Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity
Current Medicinal Chemistry Can Dietary Antioxidants Reduce the Incidence of Brain Tumors?
Current Drug Metabolism The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia
Current Medicinal Chemistry VEGF, BMP-7, Matrigel<sup>TM</sup>, Hyaluronic Acid, In Vitro Cultured Chondrocytes and Trephination for Healing of the Avascular Portion of the Meniscus. An Experimental Study in Sheep
Current Stem Cell Research & Therapy MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising
Current Pharmaceutical Design Impact of Human Immune Deficiency Virus Infection on Hepatitis C Virus Infection and Replication
Current HIV Research Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Current Pharmaceutical Design